Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Regulus Therapeutics (RGLS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Regulus Therapeutics 10628 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 USA

P: 858-202-6300

Description:

Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.

Key Statistics

Overview:

Market Capitalization, $K 27,125
Shares Outstanding, K 20,548
Annual Sales, $ 70 K
Annual Net Income, $ -48,710 K
Last Quarter Sales, $ 6,780 K
Last Quarter Net Income, $ -3,260 K
60-Month Beta 2.26
% of Insider Shareholders 5.40%
% of Institutional Shareholders 26.11%
Float, K 19,438
% Float 94.60%

Growth:

1-Year Return -84.14%
3-Year Return -98.03%
5-Year Return -98.30%
5-Year Revenue Growth -99.64%
5-Year Earnings Growth -3.52%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/09/19
Earnings Per Share ttm -4.03
EPS Growth vs. Prev Qtr 68.37%
EPS Growth vs. Prev Year 82.78%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-12 on 10/04/18

RGLS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -0.51
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -671.33
Return-on-Assets (Before Tax) -109.14
Profit Margin % -69,585.71
Net Margin % N/A
Debt/Equity N/A
Price/Sales 376.74
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.56
Interest Coverage -19.79
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar